Table 4.
Multivariable Cox regression analysis for variables associated with overall survival
| HR | 95%CI | P1 value | |
| AJCC stage | 0.004 | ||
| I | 1.00 | ||
| II | 1.59 | 0.74-3.32 | |
| III | 3.09 | 1.32-7.27 | |
| IV | 3.08 | 1.53-6.19 | |
| Treatment | 0.007 | ||
| Chemotherapy | 1.00 | ||
| None | 2.80 | 1.57-5.00 | |
| Neoadjuvant, surgery | 0.28 | 0.10-5.31 | |
| Surgery only | 0.48 | 0.15-12.61 | |
| Surgery, adjuvant | 0.19 | 0.06-5.17 | |
| Neoadjuvant, surgery, adjuvant | 0.18 | 0.5-5.31 | |
| Blood type | 0.160 | ||
| A+ | 1.00 | ||
| AB+ | 0.81 | 0.34-2.23 | |
| B+ | 1.01 | 0.45-2.24 | |
| O+ | 1.40 | 0.84-2.54 | |
| Unknown | 0.63 | 0.31-1.17 | |
| Chronic gastritis, yes vs no | 1.01 | 0.59-1.69 | 0.970 |
1
Bold type indicates statistical significance (P < 0.05). HR: Hazard ratio; CI: Confidence interval; AJCC: American Joint Committee on Cancer.